CLINICAL_TRIALS
trial_result
· 2017-12-21
Clinical Trial Update: Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients [Phase 3]
Summary
Phase 3 trial of recombinant human neuregulin-1β in chronic heart failure was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Zensun Sci. & Tech. Co., Ltd. | Conditions: Chronic Heart Failure | Phase 3 | Status: TERMINATED